Skip to main content
OpenTrials
Completed

NCT Number: NCT06593249

Management of Tick-borne Encephalitis

In this retrospective cohort study of patients with tick-borne encephalitis (TBE), potential differences in the clinical presentation at admission and diagnostic and therapeutic management of patients with TBE initially referred to infectious diseases or neurology departments were assessed. Associations between severity of acute illness and clinical outcome were also explored.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • microbiologically confirmed tick-borne meningoencephalitis

Exclusion criteria

  • Exchanged between ID and neurology within the first 48 hours due to organizational constraints
  • Transferred from another hospital
  • Lumbar puncture not performed
  • Not fulfilling study criteria

Treatment and study plan

No Intervention: Observational Cohort

Other

no intervention, observational study

Primary outcomes

  1. head imaging

    Time frame: at admission

    Number (%) of patients with head imaging performed before proceeding to lumbar puncture.

Sponsors and collaborators

Lead sponsor

University Medical Centre Ljubljana

Other

Registry information

Official study title

Presentation, Management and Outcome of Tick-borne Encephalitis in Patients Referred to Infectious Diseases or Neurology

Important dates

Study start
2022
Primary completion
2023
Study completion
2024
First posted
Sep 19, 2024
Registry last updated
Dec 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.